跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 106 条关于
“MDXX”
全部
106
临床试验
48
药物
40
机构
5
资讯
13
去年
PharmAla Biotech Unveils Phenesafe AI Platform to Accelerate MDXX Drug Discovery
去年
PharmAla Biotech Reports Strong Revenue Growth and Financial Results for Fiscal Year 2024
去年
PharmAla Files C$50 Million Shelf Prospectus to Advance MDMA Drug Development
去年
PharmAla to Supply MDMA for Clinical Trial in Exchange for Data License
去年
PharmAla to Supply MDMA for PTSD Trial at Merhavim Mental Health Centre in Israel
2年前
PharmAla Biotech to Supply LaNeo MDMA for Clinical Trials at Mt. Sinai, Harvard, and Johns Hopkins
9个月前
PharmAla Biotech Advances MDMA Manufacturing and Novel ALA-002 Development for Clinical Trials
去年
PharmAla Establishes Australian Subsidiary to Advance MDMA Clinical Research and Development
5个月前
Cortexa Achieves Major Commercial Milestone with MDMA Supply in Australia's Regulated Psychedelic Market
上个月
Jupiter Neurosciences Secures Exclusive U.S. Rights to PharmAla's ALA-002 in Deal Valued at Up to $100 Million
第 1 页,共 2 页
上一页
下一页